A CWCI study based on data from 5.75 million California workers' comp prescriptions filled between 2009 and June 2018 shows a continuing shift away from opioids and toward NSAIDs and anticonvulsants, while the payment data show that dermatological drugs and anticonvulsants now account for more of the California workers' comp drug spend than opioids.